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Mycobacterium bovis, one of several mycobacteria of the 
M. tuberculosis complex, is a global zoonotic pathogen that pri-
marily infects cattle. Humans become infected by consuming 
unpasteurized dairy products from infected cows (1,2); possible 
person-to-person airborne transmission has also been reported 
(3). In April 2014, a man in Nebraska who was born in Mexico 
was determined to have extensive pulmonary tuberculosis (TB) 
caused by M. bovis after experiencing approximately 3 months 
of cough and fever. Four months later, a U.S.-born Hispanic 
girl from a nearby town who had been ill for 4–5 months was 
also determined to have pulmonary TB caused by M. bovis. 
The only social connection between the two patients was 
attendance at the same church, and no common dietary 
exposure was identified. Both patients had pulmonary cavities 
on radiography and acid-fast bacilli (AFB) on sputum-smear 
microscopy, indicators of being contagious (4). Whole-genome 
sequencing results of the isolates were nearly indistinguishable. 
Initial examination of 181 contacts determined that 39 (22%) 
had latent infection: 10 (42%) of 24 who had close exposure 
to either patient, 28 (28%) of 100 who were exposed to one 
or both patients in church, and one (2%) of 57 exposed to the 
second patient at a school. Latent infection was diagnosed in 
six contacts on follow-up examination, 2 months after an initial 
negative test result (4), for an overall latent infection rate of 
25%. No infected contacts recalled consuming unpasteurized 
dairy products, and none had active TB disease at the initial or 
secondary examination. Persons who have M. bovis TB should 
be asked about consumption of unpasteurized dairy products 
(2), and contact investigations should follow the same guidance 
as for M. tuberculosis TB (4).
In April 2014, patient A, a man aged 42 years who was 
born in Mexico sought care for cough, fever, weight loss, and 
progressive debilitation over approximately 3 months. He had 
arrived in Nebraska from Mexico in 2010, and initially he 
worked on a dairy farm* and later in construction. No informa-
tion was collected regarding his prior employment in Mexico, 
but he did report frequent consumption of raw milk. Chest 
radiography was consistent with advanced TB with cavities; 
numerous AFB were reported from sputum-smear microscopy. 
The result from nucleic acid amplification testing of sputum 
was positive for M. tuberculosis complex. The isolate was resis-
tant both to pyrazinamide (PZA), which suggested that the 
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infection was caused by M. bovis, and to low-concentration 
isoniazid (INH) (5). His treatment regimen was adjusted in 
consultation with national experts in drug-resistant TB. He 
recovered slowly and remained isolated at home until results 
from sputum smears were negative for AFB in August. 
In June 2014, patient B, a Hispanic girl aged 16 years, who 
was born in Nebraska to Mexican parents, sought medical care 
after 2–3 months of cough. She initially received treatment for 
presumed bronchitis and allergies, without chest radiography. 
She remained ill through late July, when radiography revealed 
a pulmonary cavity and her sputum smear had numerous 
AFB. M. bovis resistant to PZA was identified after culture 
confirmation. She had never traveled outside the United States 
and was unaware of having consumed any dairy products from 
Mexico. She recovered quickly and remained in isolation at 
home until late September. The only social connection between 
patients A and B was regular attendance at the same church. 
The patients knew one another but their interactions were 
reported to be minimal.
Contact investigations were conducted in accordance with 
published guidelines (4) focusing on household contacts of 
both patients, community contacts at both the church and 
patient B’s school, coworkers of patient A, and persons who 
spent extended periods in a vehicle with him. Potentially 
exposed health care workers were notified for follow-up at their 
respective facilities with a request to report infections to the 
health department if identified. Tuberculin skin tests (TST) 
and interferon gamma release assays (IGRA) were used for test-
ing U.S.-born and foreign-born contacts, respectively; IGRA 
was used for all members of the church, where the majority 
of contacts were foreign born. Contacts whose initial results 
were negative, but whose exposure to either patient had ended 
<2 months before testing, were retested after 8–12 weeks, 
because immune sensitivity might not be detectable during this 
period after new infection (4). Persons who had positive test 
results indicating infection had chest radiographs to exclude 
active TB disease and thus establish latent infection (4).† All 
contacts were asked about their country of birth except those 
at a school attended by patient B where all were assumed to 
have been born in the United States. Midway through the 
investigation, after M. bovis was recognized as the causative 
agent, contacts who had positive test results were also asked 
about travel abroad and consumption of unpasteurized dairy 
products from Mexico.
† Tuberculosis infection is “a condition in which microorganisms [i.e., 
M. tuberculosis complex] have entered the body and typically have elicited 
immune responses” and “includes both latent infection and TB disease.” Latent 
infection “is an asymptomatic condition that follows the initial infection; the 
infection is still present but is dormant (and believed not to be currently 
progressive or invasive)” and “might progress to TB disease.” “[Active] TB 
disease is determined by finding anatomic changes caused by advancing infection 
(e.g., shadows from infiltrates on a chest radiograph) or by noting symptoms 
(e.g., malaise, feverishness, or cough), and typically by both.” http://www.cdc.
gov/mmwr/preview/mmwrhtml/rr5415a2.htm.
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Twenty-four persons had extended close exposure to either 
patient and were regarded as high-priority contacts (4); among 
these, 10 (42%) had positive results at initial testing (Table 1). 
Two were non-Hispanic U.S.-born contacts of patient A who 
did not attend the church. Among 11 high-priority contacts 
of patient B, seven were family members who were also poten-
tially exposed to patient A at the church. Among patient B’s 
five siblings, four were born in the United States, had never 
traveled abroad, and did not recall consuming dairy prod-
ucts from Mexico; three of these four siblings were infected. 
Patient B’s eldest sibling and mother, both of whom were born 
in Mexico, were also infected but neither had active TB disease 
and thus would not have been infectious. Among 100 church 
members (excluding patient B and high-priority contacts of 
either patient), 28 (28%) had latent infection, including five 
U.S.-born children. Among 57 school contacts, one U.S.-born 
child was infected. No infections among exposed health care 
workers were reported.
Among 77 persons for whom retesting was indicated, 56 
(73%) were retested, and six (11%) were determined to have 
latent infection (Table 2). During the interval between the first 
and second tests, none had traveled abroad or recalled eating 
unpasteurized dairy products from Mexico. No school contacts 
were retested, because their exposure had ended the previous 
May. No infected contacts had active TB disease, and all were 
offered a 4-month rifampin preventive regimen.§
Patient A’s bacterial isolate, grown at a private hospital labora-
tory from a sputum sample collected April 24, 2014, was sent to 
the Nebraska Public Health Laboratory to facilitate genotyping 
at the Michigan state laboratory and first-line drug susceptibil-
ity testing at Associated Regional and University Pathologists, 
Inc.; second-line drug susceptibility testing was conducted 
at CDC. Patient B’s isolate was cultured by Nebraska Public 
Health Laboratory from a sputum sample collected during 
early August, and it was similarly sent for first- and second-line 
drug susceptibility testing and genotyping. Routine genotyp-
ing results of both patients’ isolates were indistinguishable. In 
late September 2014, both patients’ isolates were sent to the 
United States Department of Agriculture National Veterinary 
Services Laboratories (NVSL) where whole-genome sequencing 
was performed. Results suggested that the two patients’ isolates 
were closely related; phylogenetic comparisons differed by only 
three single nucleotide polymorphisms (SNPs). The sequences 
did not match others in NVSL’s library, but the isolates shared 
a common ancestor with isolates from five cattle in Mexico.¶
Discussion
M. bovis primarily causes disease in cattle but also infects 
deer and other mammals (1). The human diseases caused by 
M. bovis and M. tuberculosis (i.e., the human variant) are clini-
cally indistinguishable, and cases caused by both are reported 
in U.S. TB surveillance (1,2,6,7).** Treatment differs, how-
ever, because M. bovis is inherently resistant to PZA, which is 
part of the routine initial TB treatment regimen (5). Bovine 
tuberculosis eradication programs and routine pasteurization 
of milk products have led to marked declines in M. bovis TB 
in humans (1), which accounted for 1.6% of U.S. TB cases in 
2014 (6), with regional differences (2,6–8).
Human M. bovis disease is typically attributed to consump-
tion of unpasteurized milk (or dairy products made from 
unpasteurized milk) in or imported from countries with 
affected cattle herds (1,2,7,8). Person-to-person airborne 
transmission of M. bovis has been reported infrequently, with 
uncertainty remaining about dietary exposures (3). Findings 
from contact investigations and a population study regarding 
infectiousness of M. bovis compared with M. tuberculosis are 
inconclusive (4,9,10).††
Standard nucleic acid amplification test methods detect 
the M. tuberculosis complex without distinguishing between 
M. tuberculosis and M. bovis. Although these species can be dis-
tinguished by routine genotyping, biochemical characterization 
and drug susceptibility testing, which generally provide results 
earlier, have been historically used and can increase the index 
of suspicion for M. bovis. Whole-genome sequencing can be 
used to identify species and investigate transmission. NVSL 
sequences genomes for all U.S. M. bovis animal isolates, a 
convenience sample of cattle isolates from Mexico, and human 
isolates upon request.§§
§ In August 2015, a U.S.-born 11-year-old niece of patient A, who reported 
exposure to him only at the church, became ill with shortness of breath and 
cough. During the church contact investigation, she and her parents were 
determined to have latent infection, but they had stopped taking rifampin after 
only 2 months. A presumptive diagnosis of TB disease caused by M. bovis was 
made, and treatment was started in September 2015, based on clinical findings, 
including a new pulmonary infiltrate (4,6). Results from sputum-smear 
microscopy, nucleic acid amplification test, and culture were negative.
 ¶ These cattle included four dairy cows in Nuevo León and one steer in Durango, 
Mexico. On the basis of whole-genome sequencing of 15 less related cattle 
isolates in Group 13, this M. bovis strain appears to be disseminated throughout 
Mexico but has not been identified in U.S.-origin cattle. Isolates in this group 
of the SB0121 family are believed to have evolved on the Iberian Peninsula.
 ** Genotyping results from CDC’s National TB Genotyping Service for the 
isolates from 96 TB patients with culture-confirmed disease in Nebraska 
during 2006–2013 indicated that all were M. tuberculosis.
 †† Infectious TB “refers either to TB disease of the lungs or throat, which has the 
potential to cause transmission to other persons, or to the patient who has TB 
disease.” http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a2.htm.
 §§ NVSL has sequenced 97% of M. bovis isolates from affected U.S. cattle herds 
since 1997 and 90% from feeder and feedlot cattle (both imported and 
domestic) since 2000. The oldest isolate sequenced is from 1991, but isolates 
were not consistently archived from affected herds until 1997. NVSL sequences 
the M. bovis isolates from all animal species; the size of the database is 
approximately 2,500 sequences.
Morbidity and Mortality Weekly Report 
200 MMWR / March 4, 2016 / Vol. 65 / No. 8 US Department of Health and Human Services/Centers for Disease Control and Prevention
Patient A might have been infected from consuming unpas-
teurized dairy products originating in Mexico. The timing of 
the illnesses, relatedness of the M. bovis isolates, and common 
church attendance suggest that patient B might have acquired 
infection from patient A. Findings from the contact investiga-
tions suggest possible airborne transmission, because approxi-
mately one third of the infections could not be explained 
by potential exposure in countries where M. tuberculosis 
complex infections are common. Consumption of imported 
contaminated dairy products could not be excluded, but locally 
produced dairy products were unlikely to be contaminated 
with M. bovis.
The findings in this report are subject to at least four limita-
tions. This investigation illustrates typical challenges of investi-
gating human M. bovis infections. First, the incubation period 
has not been well studied, but it potentially ranges from months 
to years and might obscure ascertainment of time and nature 
of exposure. Second, dietary history details could be forgotten 
during the interim, or consumers might be unaware of the ori-
gin or pasteurization status of dairy products they consumed. 
Third, TST and IGRA are based on cellular immune response 
and cannot distinguish between old or recent infections, or 
whether the cause is M. tuberculosis or M. bovis. Persons from 
countries where both types of infection are prevalent could 
be infected by either species. The variable incubation period 
for M. bovis notwithstanding, the six persons whose results 
changed from negative to positive were probably infected only 
in the weeks before being examined. Finally, despite not docu-
menting conversion in the first five U.S.-born high-priority 
contacts who were infected, this observed proportion of latent 
infections (29% [five of 17]) upon initial testing exceeds the 
expected background prevalence of latent infection of <2% 
for persons born in the United States.
An evidence base to aid epidemiologic interpretation of 
whole-genome sequencing results from isolates with few 
differences in SNPs has not been established for M. bovis or 
M. tuberculosis. Maintenance of patient A’s isolate in culture 
for approximately 5 months could have provided opportunity 
for accrual of the additional SNPs. Airborne transmission from 
either patient was plausible based on disease characteristics 
TABLE 2. Investigation setting and results of follow-up testing* 
performed 8–12 weeks after last potential exposure and after 
an initial negative result for contacts (N = 56) of one or both of 
two Mycobacterium bovis tuberculosis patients — Nebraska, 
October 2014
Investigation setting†
Test results 
negative
Test results 
positive Total
No. (%) No. (%) No.
High-priority contacts of patient A 0 (0) 1§ (100) 1
High-priority contacts of patient B 1 (25) 3¶ (75) 4
Church 49 (96) 2 (4) 51
Total 50 (89) 6** (11) 56
 * An interferon-gamma release assay was used for testing at the church where 
foreign-born persons predominated and for other foreign-born contacts. 
Tuberculin skin tests were used for U.S.-born contacts.
 † Follow-up testing was not necessary for contacts at patient B’s school because 
the end of their exposure was >2 months before the investigation.
 § Non-Hispanic U.S.-born individual exposed at patient A’s residence who 
reported no international travel at any time and no consumption of Mexico-
origin unpasteurized dairy products. This person had no affiliation with the 
church or the school and reported no contact with patient B, who resided in 
a different town.
 ¶ All three were patient B’s family members who were also potentially exposed 
to patient A at the church.
 ** All six denied both international travel and consumption of Mexico-origin 
unpasteurized dairy products in the interim. Among these, three were foreign 
born (two high-priority contacts of patient B and one church member).
TABLE 1. Investigation setting and results of initial testing* of contacts (N = 181) exposed to one or both of two Mycobacterium bovis tuberculosis 
patients, by United States versus foreign birth — Nebraska, 2014
Investigation setting†
Test results negative Test results positive
Total testedForeign-born U.S.-born Total negative Foreign-born U.S.-born Total positive
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No.
High-priority contacts of patient A 3 (23) 5 (38) 8 (62) 3 (23) 2§ (15) 5 (38) 13
High-priority contacts of patient B 2 (18) 4 (36) 6 (55) 2 (18) 3¶ (27) 5 (45) 11
Church 43 (43) 29 (29) 72 (72) 23 (23) 5** (5) 28 (28) 100
Patient B’s school NA NA 56 (98) 0 (0) 1** (2) 1 (2) 57
Total NA NA 142 (78) 28†† (15) 11 (6) 39§§ (22) 181
Abbreviation: NA = not available.
 * Tuberculin skin tests and interferon gamma release assays (IGRA) were used for testing U.S.-born and foreign-born contacts, respectively; IGRA was used for all 
members of the church where the majority of contacts were foreign born.
 † The counts in the four categories of settings are mutually exclusive. Among the 13 high-priority contacts of patient A, 11 did not attend the church. Among the 
remaining two who were also potentially exposed to patient B at the church, one tested positive (patient B’s grandfather). Among the 11 high-priority contacts of 
patient B, all were also potentially exposed to patient A at the church. Patients A and B were not counted as contacts for any setting.
 § Non-Hispanic U.S.-born adults exposed at patient A’s residence.
 ¶ Three Hispanic siblings of patient B (aged 7, 9, and 10 years).
 ** Six U.S.-born children. Unknown travel and dietary history.
 †† Countries of birth are Mexico (n = 26), Guatemala (n = 1), and Philippines (n = 1).
 §§ All 39 persons testing positive reported no knowledge of a prior positive TB test result, but information was lacking to verify the accuracy of their recall.
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(i.e., pulmonary cavities and AFB on sputum smears) and 
contact findings.
This report adds to the evidence for airborne person-to-
person spread of M. bovis (3,9,10). Whole-genome sequencing 
is an emerging tool for investigating transmission. Public health 
responses to M. bovis pulmonary TB should be the same as 
those for M. tuberculosis TB, with additional inquiries about 
consumption of unpasteurized dairy products. The ongoing 
incidence of M. bovis TB in humans substantiates the need to 
control bovine tuberculosis globally and to pasteurize all milk 
and dairy products.
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Summary
What is already known about this topic?
Mycobacterium bovis, a zoonotic pathogen of cattle, causes 
tuberculosis in persons who consume unpasteurized contami-
nated dairy products. Airborne person-to-person transmission 
has been suspected but is difficult to confirm.
What is added by this report?
A large contact investigation around two patients with M. bovis 
pulmonary tuberculosis and the findings from molecular 
epidemiology strengthen the evidence for person-to-person 
transmission of M. bovis infection.
What are the implications for public health practice?
The persistence of M. bovis in cattle internationally and the failure 
to pasteurize dairy products in many locations means that further 
infections in humans should be anticipated. Persons with M. bovis 
infections should be asked about foodborne exposures. Contact 
investigations for M. bovis disease should be conducted using the 
same methods as for M. tuberculosis disease.
